Tilray Brands (TLRY) Tax Provisions (2018 - 2026)
Tilray Brands (TLRY) posted Tax Provisions of $2.0 million for Q1 2026, down 44.33% on a QoQ basis from $3.5 million in Q4 2025, and up 64.09% year-over-year from $1.2 million in Q1 2025.
Tilray Brands (TLRY) Tax Provisions (2018 - 2026) Analysis & Trends
Tilray Brands' Tax Provisions history runs 9 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Tax Provisions rose 64.09% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $3.6 million (down 76.55% YoY) and the FY2025 annual result came in at $4.5 million, down 63.33% from the prior year.
- Tax Provisions was $2.0 million for Q1 2026 at Tilray Brands, down from $3.5 million in the prior quarter.
- Across five years, Tax Provisions topped out at $15.2 million in Q2 2023 and bottomed at -$10.8 million in Q1 2023.
- A 5-year average of $2.2 million and a median of $1.2 million in 2025 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 499.66% in 2023, while the deepest fall reached 490.77% in 2023.
- Tilray Brands' Tax Provisions stood at $11.7 million in 2022, then slumped by 128.86% to -$3.4 million in 2023, then surged by 160.24% to $2.0 million in 2024, then soared by 74.17% to $3.5 million in 2025, then plunged by 44.33% to $2.0 million in 2026.
- Business Quant data shows TLRY's Tax Provisions at $2.0 million in Q1 2026, $3.5 million in Q4 2025, and -$2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.97 Mn |
| Nov 30, 2025 | 3.55 Mn |
| Aug 31, 2025 | -2.29 Mn |
| May 31, 2025 | 369,000.00 |
| Feb 28, 2025 | 1.20 Mn |
| Nov 30, 2024 | 2.04 Mn |
| Aug 31, 2024 | 886,000.00 |
| May 31, 2024 | 11.24 Mn |
| Feb 29, 2024 | -2.87 Mn |
| Nov 30, 2023 | -3.38 Mn |
| Aug 31, 2023 | 7.26 Mn |
| May 31, 2023 | 15.20 Mn |
| Feb 28, 2023 | -10.81 Mn |
| Nov 30, 2022 | 11.71 Mn |
| Aug 31, 2022 | 7.21 Mn |
| May 31, 2022 | -3.80 Mn |
| Feb 28, 2022 | -1.83 Mn |
| Nov 30, 2021 | -5.67 Mn |
| Aug 31, 2021 | 4.76 Mn |
| May 31, 2021 | 29.63 Mn |